Susquehanna International Group LLP Purchases 154,978 Shares of Sotera Health Company $SHC

Susquehanna International Group LLP grew its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 304.1% in the second quarter, HoldingsChannel.com reports. The fund owned 205,943 shares of the company’s stock after acquiring an additional 154,978 shares during the quarter. Susquehanna International Group LLP’s holdings in Sotera Health were worth $3,655,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. CenterBook Partners LP boosted its position in shares of Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after purchasing an additional 73,473 shares in the last quarter. Militia Capital Management LLC acquired a new stake in Sotera Health during the first quarter worth approximately $3,877,000. Geode Capital Management LLC increased its holdings in Sotera Health by 13.8% in the fourth quarter. Geode Capital Management LLC now owns 3,931,834 shares of the company’s stock worth $69,372,000 after purchasing an additional 476,365 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in Sotera Health by 13.4% in the first quarter. Bank of New York Mellon Corp now owns 1,403,971 shares of the company’s stock worth $20,133,000 after purchasing an additional 166,055 shares in the last quarter. Finally, Balefire LLC acquired a new position in Sotera Health in the first quarter valued at approximately $1,476,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on SHC shares. Wall Street Zen upgraded Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday. JPMorgan Chase & Co. lifted their price objective on shares of Sotera Health from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Barclays boosted their target price on shares of Sotera Health from $19.00 to $22.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Weiss Ratings raised shares of Sotera Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Finally, The Goldman Sachs Group initiated coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price target for the company. Eight equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $21.50.

Insider Buying and Selling

In related news, insider Michael P. Rutz sold 150,000 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $18.84, for a total value of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares in the company, valued at $6,297,816.36. This trade represents a 30.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Chairman Michael B. Jr. Petras sold 850,000 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $18.50, for a total value of $15,725,000.00. Following the completion of the transaction, the chairman owned 3,969,393 shares in the company, valued at approximately $73,433,770.50. This represents a 17.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 1,294,515 shares of company stock worth $23,999,528 over the last ninety days. 15.36% of the stock is owned by insiders.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $19.27 on Monday. The business has a 50-day simple moving average of $18.12 and a 200 day simple moving average of $16.40. Sotera Health Company has a one year low of $13.09 and a one year high of $19.85. The company has a debt-to-equity ratio of 3.33, a current ratio of 2.80 and a quick ratio of 2.55. The firm has a market capitalization of $5.50 billion, a price-to-earnings ratio of 33.81 and a beta of 1.77.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 40.12% and a net margin of 13.44%.The business had revenue of $321.38 million for the quarter, compared to analyst estimates of $309.70 million. During the same quarter in the prior year, the company earned $0.20 earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.950-1.010 EPS. On average, research analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.